University Malaya to create kidney transplantation research centre network following myKidney launchApril 17, 2019
The launch of myKidney by Raja Permaisuri Perak, Tuanku Zara Salim at University of Malaya (UM) recently set stage for the creation of the 'Transplantation Research Centre' network which is envisaged to be the backbone of Research & Development in the area of kidney transplant in Malaysia.
With the tagline “Be someone’s reason to be Alive”, myKidney project aims to develop talent and strengthen knowledge, thus increasing the number of transplants in the country. Dialysis patients increase by 2.5-fold The 24th Report of the Malaysian Dialysis & Transplant Registry 2016 stated that there were 37,183 patients receiving dialysis, a 2.5-fold increase as compared to the last decade. Despite the rapid increase in dialysis population, the number of kidney transplantation performed in patients had remained very low, with not more than 100 cases per annum for the past years. As of October 2018, there were 25,000 kidney patients in the country still waiting to undergo kidney transplant procedures. “myKidney is an integrated Corporate Social Responsibility project under the CEO@Faculty Programme 2.0, Ministry of Education Malaysia, established to organise efforts from interested stakeholders towards a concerted approach for patients with chronic kidney disease”, said Associate Professor Dr Ivy Chung, Director of myKidney Launch and Fun Run 2019. Dr Rafidah Abdullah, Consultant Nephrologist and Head of Department at Hospital Sultan Haji Ahmad Shah, Temerloh, Pahang highlighted that chronic kidney disease may eventually result in complete kidney failure. "When the kidneys totally fail, either dialysis or a kidney transplant is required. Dialysis does not cure end-stage renal disease. A transplant offers the closest thing to a normal life because the transplanted kidney can replace the failed kidneys," she said. Professor Dr Arham Abdullah, Director of Industry Relations Division, Ministry of Education Malaysia, explained that myKidney project will be one example of how critical social issues such as inadequate kidney transplant in our country can be dealt with through integrated collaboration. “Knowledge alone is inadequate, even the spirit of empathy and strengthening the powerful collaboration can reduce the gap among the parties with its own direction. Such an effort is compatible with our public education philosophy, and as such, it is desirable to officially launch myKidney project”, he added. Earlier before the launching, myKidney Fun Run was flagged-off with more than 500 participation from the public. Fund raised from the run will be channeled to a Patient Welfare Account at University of Malaya Medical Centre (UMMC) and will be used to assist underprivileged chronic kidney disease patients who require a kidney transplant. |
EXPLORE FURTHER
Diabetes: The top cause of chronic kidney disease1 in 3 adults with diabetes suffer from chronic kidney disease (CKD) and it affects up to 40% of patients with Type 2 diabetes.
|
Early warning signs of kidney cancerTumors often discovered incidentally; symptoms include painless haematuria and swelling
|
Pros and cons of getting a kidney transplantOnly half of dialysis patients survive five years post-treatment
|
Nephrologist says only 30 get into kidney donation programme from 21,000 in waiting listThe average waiting time for an organ transplant is between 14 and 16 years
|
National Kidney Foundation refutes claims of viral posting promoting a cure for kidney diseaseJisheng Kidney Qi tablets - a cure for kidney disease a scam, says NKF
|
Cranberries, high doses of vitamin C causes kidney stones, says clinical journalOxalate in cranberries a contributing factor
|
Mybuahpinggang.com website launched to empower kidney failure patients, caregivers nationwidePractical resources on kidney diseases, treatment, dialysis and transplant
|
National Kidney Foundation launches Red Bean assistance programme to aid patients with anemiaEnhancing CKD care with effective erythropoietin-stimulating agent (ESA) treatment for patients
|


